We have the good fortune of having the following four top experts in their respective fields offer their opinions of the Mini-Infuser™. Some of their full quotes or excerpts have already been posted throughout this website. These clinicians are respected in their fields, come from diverse backgrounds, and most importantly are very familiar with the Mini-Infuser™.
“The Medipacs® Mini-Infuser™ is an incredible device for the future delivery of medications in the Newborn and Pediatric Medicine field. Infants and children who once had to spend extra days and weeks as inpatients in hospitals, where they are at risk for acquiring serious infections, will be able to receive their medications at home with new safety, accuracy and simplicity. Medipacs® will deliver these patients their medications via new technology that assures precise doses via a device that will showcase an ease of use that allows their physicians to fine-tune their therapy in conjunction with other health-care providers to assure the delivery of excellent care.
Medipacs® will deliver medications in tiny or large doses accurately and in intervals as required and will do so over a number of doses as needed. These devices are disposable and are reasonable in cost and so portable that a lifestyle can be maintained while important therapy is given. In a healthcare system that is rapidly evolving and requiring that we develop innovative technology that provides our patients the excellent care they deserve while conserving our health care dollars, Medipacs® is truly a home run for all! My infant and pediatric patients will be able to go home and get the nurturing of family while getting their life-saving medications – and at a significant cost savings to the family and our community as a whole!”
“The clients really want their pets to be comfortable after surgery, and when you’ve had an animal who’s had multiple traumas and fractures, pain control is essential.”
“I like the idea”, Dr Wishnak says, “of having a send-home pack that you can use with a constant rate of infusion of multiple analgesics. This gives us the flexibility of using medications we normally can’t use at home. They (the clients) like the fact that their pet is home and we can change out the Mini-Infuser™ and put in a new amount of medication.”
* DPB is committed to providing the highest quality clinical and leadership education in hospice and palliative care
In today’s hospice setting, where pain management can be a very complex process, the Medipacs® Mini-Infuser™ will offer many benefits. Since most hospice patients are cared for in the home by family, the Mini-Infuser™ will provide high-level pain management without requiring the patient or family to go through significant training to manage this device. It will offer the hospice nurse an efficient and effective analgesic delivery system with a high level of safety.
This pump platform infusion device provides a new approach to small volume parenteral drug administration. It combines the accuracy of electronically controlled pump technology with the low cost and convenience of a disposable, wearable infusion device. The device comes in a disposable package and can deliver precise administration of small fluid volumes via subcutaneous access. This delivery system offers less dramatic swings in analgesic blood level. This should improve the patient’s pain experience. There is no complicated setup, nor the extensive patient teaching that is associated with the use of PCA. Unlike PCA, the patient is free of intravenous lines, poles, and monitors and may ambulate. It will also be a great benefit to palliative care of cancer patients where an IV may not be necessary.
Pain management medication administration errors, and infection are key issues important to the Joint Commission. Use of this device has the potential to impact patient care in several ways. Nurses may make pain assessments and initiate dose administration on a single patient visit, providing patients with faster pain relief. The nurse will make fewer trips to get pain medications compared to bolus injections. Fewer trips means fewer chances for serious administration errors. No bedside dose preparation and associated drug waste is required. Disposable pumps significantly eliminate infection risks as no cleaning or disinfection is required.
Venipuncture is one of the top causes of traumatic neuropathic pain in hospital settings. With the subcutaneous injection, you minimize this risk. Subcutaneous use reduces IV infections, lowers nursing requirements and decreases the risks for traumatic neuropathic pain.
I believe that the Medipacs® product has the potential to make a significant difference in patient outcomes, safety, clinician efficiency, and treatment costs.